NewslettersMuscle Cell News VSMC-Specific TRPC1 Deletion Attenuates Angiotensin II-Induced Hypertension and Cardiovascular Remodeling By Jamie Kang - January 2, 2025 0 126 Investigators found increased transient receptor potential canonical 1 (TRPC1) expression in angiotensin II (AngII)- treated vascular smooth muscle cells (VSMCs) and aortas from angiotensin II-infused mice. [Journal of Molecular Medicine] Abstract